Clicky

Neurotech International Ltd  (NTI)

Description: Neurotech International Limited (Neurotech) is an Australia-based medical device and solutions company. The Company is focused on developing neuro-stimulation and neuro-diagnostic solutions. The Company delivers its solutions through the mente platform, a platform technology to enable medical practitioners to remotely monitor and play an active role in home-based therapies. Its product, Mente Autism, assists with the management of children with Autism Spectrum Disorder (ASD). Mente Autism is an electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to help relax the minds of children with ASD. It has a pipeline of products, which are split between the business-to-consumer (B2C) or end user/consumer family of products for home-use, such as Neurotech first product, Mente Autism, and the business-tobusiness (B2B) or business-focused family of products for clinical use. It operates through its subsidiary, AAT Research.


Keywords: Medicine Medical Device Neuroscience Psychiatric Diagnosis Psychiatry B2B Platform Technology Electroencephalography Autism Autism Spectrum Disorder

Home Page: www.neurotechinternational.com

NTI Technical Analysis

Columbia Funds Series Trust
,

Phone: 61 8 9389 3130


Officers

Name Title
Dr. Alexandra Andrews Chief Operating Officer
Prof. Allan Cripps A.O., AO, B.Sc., Ph.D. Chief Scientist & Innovation and Director
Dr. Emanuela Russo Chief Scientific Officer & Member of Scientific Advisory Board
Mr. Gerald Quigley Director of PR & Director
Dr. Thomas Duthy M.B.A., Ph.D. Exec. Director
Mr. Peter James Lawrence Griffiths B.Sc. Chief Exec. Officer of AAT Research Ltd
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 44.0107
Price-to-Sales TTM: 96.9368
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks